Aptevo Therapeutics (APVO) Institutional Ownership $0.46 -0.04 (-8.42%) As of 12:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Aptevo Therapeutics (NASDAQ:APVO)CurrentInstitutional OwnershipPercentage8.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$313.86MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$87.67K Get APVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Aptevo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data APVO Institutional Buying and Selling by Quarter Aptevo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/11/2025Virtu Financial LLC21,627$93K0.0%-48.5%4.241% 8/15/2024Armistice Capital LLC749,234$229K0.0%N/A18.359% 11/15/2023Sabby Management LLC1,334,169$440K0.3%N/A11.581% 11/15/2023Armistice Capital LLC1,235,000$408K0.0%N/A10.717% 2/1/2023Bank of Montreal Can10,000$61K0.0%N/A0.196% 11/15/2022Cantor Fitzgerald L. P.133,700$406K0.0%N/A2.627% 11/7/2022Virtu Financial LLC28,421$86K0.0%+122.6%0.558% 12/10/2021Towercrest Capital Management211,227$3.26M0.6%N/A4.313% 12/8/2021Moors & Cabot Inc.389,269$3.73M0.2%N/A7.948% 11/15/2021Franklin Resources Inc.15,650$242K0.0%N/A0.320% Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2021GSA Capital Partners LLP13,651$211K0.0%N/A0.279% 11/12/2021Renaissance Technologies LLC143,419$2.21M0.0%-10.3%2.931% 11/9/2021BlackRock Inc.55,394$856K0.0%+1.9%1.133% 11/5/2021Moors & Cabot Inc.389,269$3.73M0.3%N/A7.954% 8/17/2021Balyasny Asset Management LLC18,012$404K0.0%-70.6%0.405% 8/17/2021Boothbay Fund Management LLC15,350$344K0.0%+4.9%0.345% 8/16/2021Alyeska Investment Group L.P.139,172$3.12M0.0%-80.9%3.127% 8/16/2021Morgan Stanley8,364$187K0.0%+163.4%0.188% 8/16/2021Kennedy Capital Management Inc.187,995$4.22M0.1%N/A4.225% 8/16/2021State Street Corp10,973$246K0.0%N/A0.247% 8/13/2021Renaissance Technologies LLC159,923$3.59M0.0%-23.6%3.594% 8/13/2021Anson Funds Management LP35,587$798K0.1%-26.6%0.800% 8/13/2021Northern Trust Corp22,652$508K0.0%+170.7%0.509% 8/13/2021QS Investors LLC15,650$352K0.0%+37.3%0.352% 8/13/2021Geode Capital Management LLC38,917$872K0.0%+8.8%0.875% 8/13/2021Vanguard Group Inc.134,760$3.02M0.0%+2.9%3.028% 5/17/2021Schonfeld Strategic Advisors LLC9,700$296K0.0%-12.6%0.218% 5/14/2021RTW Investments LP281,402$8.59M0.1%-2.4%6.324% 5/14/2021Dynamic Technology Lab Private Ltd14,022$428K0.0%+6.2%0.315% 5/13/2021QS Investors LLC11,400$348K0.0%N/A0.256% 5/13/2021JBF Capital Inc.3,907$119K0.0%+49.9%0.088% 5/13/2021Renaissance Technologies LLC209,223$6.39M0.0%-17.8%4.702% 5/13/2021 Bank of New York Mellon Corp9,964$305K0.0%N/A0.224% 5/13/2021Bank of Montreal Can25,280$674K0.0%-20.1%0.568% 5/12/2021Geode Capital Management LLC35,762$1.09M0.0%+26.8%0.804% 5/7/2021BlackRock Inc.57,605$1.76M0.0%-1.0%1.294% 3/8/2021Dimensional Fund Advisors LP5,502$202K0.0%N/A0.126% 2/25/2021Dimensional Fund Advisors LP5,502$202K0.0%N/A0.126% (Data available from 1/1/2016 forward) APVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of APVO shares? During the previous two years, the following institutional investors and hedge funds held shares of Aptevo Therapeutics shares: Sabby Management LLC ($440K), and Armistice Capital LLC ($229K), Virtu Financial LLC ($93K).Learn more on APVO's institutional investors. What percentage of Aptevo Therapeutics stock is owned by institutional investors? 8.06% of Aptevo Therapeutics stock is owned by institutional investors. Learn more on APVO's institutional investor holdings. Which institutional investors have been buying Aptevo Therapeutics stock? The following institutional investors have purchased Aptevo Therapeutics stock in the last 24 months: Armistice Capital LLC ($1.98M), and Sabby Management LLC ($1.33M). How much institutional buying is happening at Aptevo Therapeutics? Institutional investors have bought a total of 3,318,403 shares in the last 24 months. This purchase volume represents approximately $51.38B in transactions. Which Aptevo Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Aptevo Therapeutics stock in the last 24 months: Virtu Financial LLC ($20.34K). How much institutional selling is happening at Aptevo Therapeutics? Institutional investors have sold a total of 20,340 shares in the last 24 months. This volume of shares sold represents approximately $87.67K in transactions. Related Companies GLTO Major Shareholders PPBT Major Shareholders ONVO Major Shareholders PALI Major Shareholders SNPX Major Shareholders GENE Major Shareholders ENVB Major Shareholders SPRB Major Shareholders IMCC Major Shareholders MTNB Major Shareholders This page (NASDAQ:APVO) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APVO Stock Free APVO Stock Alerts